Excerpt:
"Not only is the new RSV vaccine not safe and effective, early results suggest it makes the disease worse
Bear in mind, they are experimenting on the youngest of the young: babies from 5 months to 2 years of age, and we are dealing with a disease that 90% of babies will catch in their first two years. Some of these babies will get a severe life threatening disease, but as I reported last month, the ones who are deficient in vitamin D are 5 to 10 times more likely to end up in intensive care. We can already do a lot to protect these babies, more cheaply and with far less risk than testing immature and complex therapies.

Maryanne Demasi reports that things are looking bad for the new RSV vaccine:

Moderna’s mRNA vaccine against RSV takes a tumble
The latest trial data demonstrates the dangerous speed of innovation.

This week, the Food and Drug Administration (FDA) disclosed that vaccinated children in the trial experienced higher rates of severe RSV compared to those in the placebo group.

The data was striking: 12.5% of vaccinated children developed severe or very severe RSV disease, compared to just 5% in the placebo group.

Moreover, among those who developed symptomatic RSV, 26.3% of vaccinated participants progressed to severe illness, sharply contrasting with the 8.3% in the placebo group.

The trials were stopped in July after five babies aged 5 to 8 months developed severe cases of RSV. The FDA has since put the experiment on hold."